Search PDMR transactions

Notifier
Name of person with notification obligation
Oncolution AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Thomas Pollare
Position
Chairman of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
AlzeCure Pharma AB
Issuer´s LEI code
5493001EJLEBXFY6I446
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA AlzeCure Pharma AB BTA SE0017563208 Acquisition 352,750 Quantity 4.00 SEK 17/03/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
AlzeCure Pharma AB BTA SE0017563208 Acquisition 17/03/2022 NASDAQ STOCKHOLM AB 352,750 (Quantity) 4.00 SEK
Total: 352,750
<< Back